Completed NA INTERVENTIONAL 2-arm NCT05680311

Autotaxin: a Potential Biomarker for Breast Cancer.

Is Autotaxin a Promising Biomarker for Breast Cancer

Sponsor: Ankara Etlik City Hospital

Interventions measurement of serum autotaxin serum level

Updated 4 times since 2023 Last updated: Jan 25, 2023 Started: Jan 1, 2019 Primary completion: Dec 31, 2020 Completion: Mar 15, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Breast Cancer and is currently completed. Ankara Etlik City Hospital leads this study, which shows 4 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2023 — Jul 2024 [monthly]

Completed NA

First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ankara Etlik City Hospital
Diskapi Yildirim Beyazit Education and Research Hospital

Data source: Ankara Etlik City Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ankara, Turkey (Türkiye)